Semaglutide is a prescription GLP-1 receptor agonist that mimics a natural hormone involved in appetite and blood sugar control
Under a simulation model, even a narrow expansion of coverage for GLP-1s comes at a cost because the prices are so high
Funding This work was supported by grants from the National Natural Science Foundation of China (NSFC Numbers 81672800, 81603009, 81673020, 81802632, and 82173830), Natural Science Foundation of Shaanxi (2020JQ-445), and the Key Research and Development Program of Shaanxi Province (2021SF-207, 2021SF-223, and 2022ZDLSF05-19)
To overcome this unmet clinical need, newer anti-obesity drugs must exhibit not only sufficient and long-lasting weight loss but also obvious cardiovascular benefits
Dymek M, Olechowska K, Hc-Wydro K, Sikora E (2023) Liposomes as carriers of GHK-Cu tripeptide for cosmetic application